AI-assisted, human-published

07/23/2025 /Funding Events

Dash Bio Raises $11 Million to Revolutionize Drug Development with Automated Bioanalysis Platform

Dash Bio secures $11 million in additional funding, bringing the total raised capital to $17.5 million, to further develop and expand their cutting-edge bioanalysis platform.

 

AI-assisted, human-published

Latest headlines







join us

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here

©2023 VentureCapital.com